12.34 pm | 10 May 2012 |  Source: Moneycontrol.com

Pharma major Ranbaxy on Wednesday beat street estimates with a four-fold year-on-year jump in first quarter net profit at Rs 1,247 crore. However, ma...

5.39 pm | 09 May 2012 |  Source: Moneycontrol.com

Pharma major Ranbaxy on Wednesday beat street estimates with a four-fold year-on-year increase in first quarter net profit at Rs 1,247 crore, helped b...

3.36 pm | 09 May 2012 |  Source: Reuters

Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cho...

2.30 pm | 09 May 2012 |  Source: Moneycontrol.com

Pharma major Ranbaxy Wednesday reported a significantly better-than-expected four-fold year-on-year increase in consolidated net profit at Rs 1,247 cr...

9.49 am | 09 May 2012 |  Source: Moneycontrol.com

Pharmaceutical firm Ranbaxy Laboratories is expected to report a growth of 34% year-on-year in its profit after tax at Rs 408 crore for the first quar...

2.45 pm | 05 Apr 2012 |  Source: Moneycontrol.com

According to the report on earnings preview for the quarter ended March 2012, KR Choksey expects the pharma sector will show strong performance in the...

12.34 pm | 24 Feb 2012 |  Source: Moneycontrol.com

Ranbaxy's fourth quarter earnings got a mixed response from the street on Friday. The stock rose about 1% in early trade but slipped below Thursday's ...

3.30 pm | 23 Feb 2012 |  Source: Moneycontrol.com

Pharma major Ranbaxy Laboratories reported a consolidated net loss of Rs 2,983 crore in the fourth quarter, compared with Rs 97.5 crore loss a year ag...

9.40 am | 23 Feb 2012 |  Source: Moneycontrol.com

Ranbaxy Laboratories is to announce its Q4CY11. According to CNBC-TV18 estimates, the company's Q4CY11 revenues are seen up 48% to Rs 3156 crore versu...

9.37 am | 23 Feb 2012 |  Source: Moneycontrol.com

Ranbaxy Laboratories is to announce its Q4CY11. According to CNBC-TV18 estimates, the company's Q4CY11 revenues are seen up 48% to Rs 3156 crore versu...

1.18 pm | 31 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Praful Borah of Nirmal Bang Institutional Equities speak about Glenmark, Divi's results and gives his outlook going forw...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

6.20 pm | 11 Jan 2012 |  Source: Moneycontrol.com

KRChoksey has come with its December quarterly earning estimates for Pharma sector. According to the research firm, Q3FY12 is expected to be a strong ...

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...